ClassID:

21256

A61K45/06 - page 38 - CPC Classification

Classification description:

Medicinal preparations containing active ingredients not provided for in groups  -  Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Recent Application in this class:
#11101
20220185897
2022-06-16

ANTI-AXL ANTIBODIES

#11102
20220185894
2022-06-16

BINDING MOLECULES BINDING PD-L1 AND LAG-3

#11103
20220185891
2022-06-16

METHODS OF ANTI-TUMOR THERAPY

#11104
20220185884
2022-06-16

Anti-CD100 antibodies and methods for using the same

#11105
20220185883
2022-06-16

METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3

#11106
20220185872
2022-06-16

METHOD FOR INHIBITING PLATELET DERIVED GROWTH FACTOR SIGNALING WITH C3aR OR C5aR ANTIBODIES

#11107
20220185856
2022-06-16

Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereof

#11108
20220185849
2022-06-16

PROTEINS FOR THE TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERS

#11109
20220185827
2022-06-16

PHARMACEUTICAL COMPOUNDS AND THERAPEUTIC METHODS

#11110
20220185804
2022-06-16

Benzazole compounds and methods for making and using the compounds

#11111
20220185803
2022-06-16

Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer

#11112
20220185778
2022-06-16

PROLYL HYDROXYLASE INHIBITORS

#11113
20220185767
2022-06-16

NOVEL TERNARY MOLECULAR COMPLEX OF TAMIBAROTENE FOR CANCER STEM CELLS TREATMENT

#11114
20220184620
2022-06-16

Micro- and nano-fluidic chip, method of fabricating the same, and applications thereof

#11115
20220184212
2022-06-16

PHARMACEUTICAL FORMULATIONS CONTAINING LIPOIC ACID DERIVATIVES

#11116
20220184209
2022-06-16

THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

#11117
20220184187
2022-06-16

Combination treatment for atopic dermatitis

#11118
20220184185
2022-06-16

MRNA BASED ENZYME REPLACEMENT THERAPY COMBINED WITH A PHARMACOLOGICAL CHAPERONE FOR THE TREATMENT OF LYSOSOMAL STORAGE DISORDERS

#11119
20220184182
2022-06-16

PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE

#11120
20220184179
2022-06-16

TREATMENT OF CANCERS WITH GM-CSF ANTAGONISTS

#11121
20220184177
2022-06-16

Polypeptides for treatment of cancer

#11122
20220184172
2022-06-16

AMPK/CASPASE-6 AXIS CONTROLS LIVER DAMAGE IN NONALCOHOLIC STEATOHEPATITIS

#11123
20220184168
2022-06-16

Stamina-improving composition and stamina-improving natural tea comprising same

#11124
20220184164
2022-06-16

PREPARATIONS CONTAINING BERRY EXTRACTS FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF VIRAL INFECTIONS CAUSED BY HERPESVIRIDAE

#11125
20220184163
2022-06-16

Preparations containing berry extracts for use in the prophylaxis and/or treatment of viral infections caused by Paramyxoviridae

#11126
20220184151
2022-06-16

MEDICINAL VAGINAL LACTOBACILLUS COCKTAIL

#11127
20220184150
2022-06-16

THERAPEUTIC MICROBIOTA FOR THE TREATMENT AND/OR PREVENTION OF FOOD ALLERGY

#11128
20220184123
2022-06-16

Genetically Engineered Cells and Uses Thereof

#11129
20220184116
2022-06-16

MEDICAL AND NUTRITIONAL COMPOSITIONS AND METHODS OF USE

#11130
20220184115
2022-06-16

Polymer nanoparticle, polymer composition, method of making a polymer nanoparticle, method for treatment of bacterial biofilms, and method for detection of bacterial biofilms

#11131
20220184111
2022-06-16

METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY

#11132
20220184105
2022-06-16

PHARMACEUTICAL COMPOSITION INJECTABLE INTO URINARY TRACT ORGAN CAVITY FOR PREVENTION OR TREATMENT OF UROTHELIAL CANCER

#11133
20220184103
2022-06-16

COMBINATION THERAPY FOR CANCER TREATMENT

#11134
20220184101
2022-06-16

Parasite therapy

#11135
20220184097
2022-06-16

Betulin-containing birch bark extracts and their formulation

#11136
20220184090
2022-06-16

COMBINATION PRODUCTS WITH TYROSINE KINASE INHIBITORS AND THEIR USE

#11137
20220184088
2022-06-16

Uses of DPP IV inhibitors

#11138
20220184079
2022-06-16

FORMULATIONS OF A COMPOUND MODULATING KINASES

#11139
20220184058
2022-06-16

PHARMACEUTICAL COMPOSITION FOR TREATING AORTIC ANEURYSM

#11140
20220184057
2022-06-16

COMBINATION TREATMENT OF OCULAR INFLAMMATORY DISORDERS AND DISEASES

#11141
20220184052
2022-06-16

COMPOSITION COMPRISING FEXOFENADINE

#11142
20220184047
2022-06-16

HISTONE DEACETYLASE AS A MODULATOR OF PDLI EXPRESSION AND ACTIVITY

#11143
20220184043
2022-06-16

METHODS OF TREATING INFLAMMATORY BOWEL DISEASE WITH AMD3100 AND TACROLIMUS

#11144
20220184037
2022-06-16

PHARMACEUTICAL AGENTS TARGETING CANCER STEM CELLS

#11145
20220184036
2022-06-16

Methods of treating HIV-associated neurological disorders (HAND)

#11146
20220184032
2022-06-16

INDOLINE DERIVATIVES FOR TREATMENT AND/OR PREVENTION OF FIBROSIS DISEASES

#11147
20220184031
2022-06-16

Dual antagonist of PGD/DPr2 and Thromboxane A/TPr receptors and use for treatment of maladaptive immune response or thrombotic diathesis

#11148
20220184026
2022-06-16

COMPOSITIONS OF FULVIC ACID AND CANNABINOID AND USES THEREOF

#11149
20220184025
2022-06-16

NOVEL DEPSIDE DIMERIC COMPOUNDS FOR SKELETAL MUSCLE MODULATION, METHODS AND USES THEREOF

#11150
20220184021
2022-06-16

NOVEL FORMULATIONS COMPRISING MELFLUFEN

#11151
20220184016
2022-06-16

BENZOQUINONE DERIVATIVE E3330 IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER AND ANGIOGENESIS

#11152
20220184013
2022-06-16

USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMENT OF CANCER

#11153
20220184012
2022-06-16

Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy

#11154
20220184009
2022-06-16

Prevention and treatment of diabetic nephropathy

#11155
20220184008
2022-06-16

MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION

#11156
20220183996
2022-06-16

High-Efficiency Transdermal Patches

#11157
20220183995
2022-06-16

SLEEP AID TRANSDERMAL PATCH AND ITS PROCESS OF PREPARATION

#11158
20220183992
2022-06-16

Edible Film Comprising Adjacent Conjoined Strips

#11159
20220183987
2022-06-16

Pharmaceutical compositions of pimobendan

#11160
20220183984
2022-06-16

Synthetic progestogens and pharmaceutical compositions comprising the same

#11161
20220183983
2022-06-16

Extended release pharmaceutical formulation

#11162
20220183982
2022-06-16

Multiple Unit Dosage Form Having A Therapeutic Agent In Combination With A Nutritional Supplement

#11163
20220183971
2022-06-16

POWDER FORMULATION FOR INTRANASAL ADMINISTRATION, AND MANUFACTURING METHOD THEREOF

#11164
20220183970
2022-06-16

CHEWABLE PHARMACEUTICAL DOSAGE FORMS

#11165
20220178947
2022-06-09

Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell

#11166
20220178927
2022-06-09

BIOMARKERS FOR SELINEXOR

#11167
20220177978
2022-06-09

METHODS OF PREDICTING AND PREVENTING CANCER IN PATIENTS HAVING PREMALIGNANT LESIONS

#11168
20220177891
2022-06-09

HIPK INHIBITORS AND METHODS OF USE THEREOF

#11169
20220177889
2022-06-09

MicroRNA-198 as a tumor suppressor in ovarian cancer

#11170
20220177888
2022-06-09

Modified short interfering nucleic acid (siNA) molecules and uses thereof

#11171
20220177846
2022-06-09

Genome-edited induced pluripotent stem cells, and cells derived therefrom, and uses thereof

#11172
20220177845
2022-06-09

Production of red blood cells and platelets from stem cells

#11173
20220177703
2022-06-09

'SMART' HYDROGEL FOR THE RADIOSENSITIZATION AND SUSTAINED DELIVERY OF THERAPEUTICS TRIGGERED BY IRRADIATION

#11174
20220177587
2022-06-09

METHODS AND USES OF VARIANT CD80 FUSION PROTEINS AND RELATED CONSTRUCTS

#11175
20220177574
2022-06-09

FcgammaRIIB-Specific Antibodies and Methods of Use Thereof

#11176
20220177570
2022-06-09

USE OF THE IL-1BETA BINDING ANTIBODY CANAKINUMAB FOR TREATING OR ALLEVIATING SYMPTOMS OF PULMONARY SARCOIDOSIS

#11177
20220177569
2022-06-09

Bispecific Antibodies for use in treatment of NLRC4-GOF inflammasomapathy

#11178
20220177561
2022-06-09

Models and Methods Useful for the Treatment of Serrated Colorectal Cancer

#11179
20220177553
2022-06-09

Antibody molecules to dengue virus and uses thereof

#11180
20220177541
2022-06-09

T cell receptors

#11181
20220177535
2022-06-09

Methods of using interleukin-2 agents

#11182
20220177495
2022-06-09

Pyridinamine-pyridone and pyrimidinamine-pyridone compounds

#11183
20220177491
2022-06-09

Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors

#11184
20220177487
2022-06-09

FUSED POLYCYCLIC PYRIDONE COMPOUNDS AS INFLUENZA VIRUS REPLICATION INHIBITORS

#11185
20220177476
2022-06-09

Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide

#11186
20220177473
2022-06-09

Azaaromatic amide derivatives for the treatment of cancer

#11187
20220177472
2022-06-09

Imidazoquinoline compounds and prodrugs thereof

#11188
20220177449
2022-06-09

GLP-1R modulating compounds

#11189
20220177430
2022-06-09

SULFINYLPYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER

#11190
20220175977
2022-06-09

COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY

#11191
20220175972
2022-06-09

Fluorochemical targeted therapies

#11192
20220175957
2022-06-09

DELIVERY OF MACROMOLECULES INTO THE CENTRAL NERVOUS SYSTEM VIA THE BLOODSTREAM

#11193
20220175948
2022-06-09

TREATMENT OF CAR T-CELL TOXICITY

#11194
20220175927
2022-06-09

Pharmaceutical compositions comprising meloxicam

#11195
20220175926
2022-06-09

TARGETED SYNERGISTIC CANCER IMMUNOTHERAPY

#11196
20220175919
2022-06-09

THERAPEUTIC AGENTS FOR PANCREATIC CANCER

#11197
20220175914
2022-06-09

Method and system for protecting monarch butterflies from pesticides

#11198
20220175907
2022-06-09

Compositions, methods and uses for thermally stable multi-targeted antigens

#11199
20220175895
2022-06-09

Method for preventing or treating metabolic disorder

#11200
20220175887
2022-06-09

METHODS AND COMPOSITIONS FOR TREATING CONDITIONS USING RECOMBINANT SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRUS

#11201
20220175883
2022-06-09

Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist

#11202
20220175879
2022-06-09

THERAPY FOR SUBARACHNOID HEMORRHAGE AND ISCHEMIA

#11203
20220175877
2022-06-09

METHODS AND COMPOSITIONS COMPRISING A C-TERMINAL BAX PEPTIDE

#11204
20220175873
2022-06-09

Synthetic neuromodulatory peptides

#11205
20220175862
2022-06-09

CO-ADMINISTRATION COMPOSITION FOR PREVENTING OR TREATING HYPERCHOLESTEROLEMIA, CONTAINING BALLOON-FLOWER EXTRACT OR PLATYCODIN D DERIVED THEREFROM AS ACTIVE INGREDIENT

#11206
20220175859
2022-06-09

Tetraselmis Extract

#11207
20220175837
2022-06-09

METHODS FOR PRODUCING REGULATORY B CELLS AND USES THEREOF

#11208
20220175836
2022-06-09

PRIMING WITH TARGETED ACTIVATED T CELLS CAN ENHANCE CHEMO RESPONSIVENESS OF CANCER CELLS

#11209
20220175824
2022-06-09

Sulfonated polystyrene derivative for use in the treatment and/or prophylaxis of cat flu

#11210
20220175815
2022-06-09

COMBINATION THERAPIES BASED ON PD1 AND IL-17B INHIBITORS

#11211
20220175813
2022-06-09

Methods for treating or preventing ophthalmological conditions

#11212
20220175808
2022-06-09

Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists

#11213
20220175797
2022-06-09

OPHTHALMOLOGIC IRRIGATION SOLUTIONS AND METHOD

#11214
20220175793
2022-06-09

THE USE OF AN MGLUR5 ANTAGONIST FOR TREATING OPIOID ANALGESIC TOLERANCE

#11215
20220175791
2022-06-09

Methods for Predicting Neisseria Spp. Susceptibility to Cefixime

#11216
20220175789
2022-06-09

EZH2 inhibitors for treating lymphoma

#11217
20220175788
2022-06-09

6-heterocyclyl-4-morpholin-4-ylpyridine-2-one compounds useful for the treatment of cancer and diabetes

#11218
20220175787
2022-06-09

PATIENT SELECTION FOR ENHANCEMENT OF ANTI-TUMOR IMMUNITY IN CANCER PATIENTS

#11219
20220175786
2022-06-09

PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER

#11220
20220175785
2022-06-09

USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)

#11221
20220175779
2022-06-09

COMPOUNDS AGAINST CANCER BEARING TYROSINE KINASE INHIBITOR RESISTANT EGFR MUTATIONS

#11222
20220175777
2022-06-09

Inhibitors of Multidrug Resistance Transporter P-Glycoprotein

#11223
20220175775
2022-06-09

N-substituted indole derivatives as PGE2 receptor modulators

#11224
20220175771
2022-06-09

CANCER TREATMENT MODALITIES

#11225
20220175770
2022-06-09

TREATMENT OF HEPATOCELLULAR CARCINOMA CHARACTERIZED BY HEPATITIS B VIRUS INFECTION

#11226
20220175768
2022-06-09

FGFR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF UROTHELIAL CARCINOMA

#11227
20220175767
2022-06-09

Uses of Bcl-2 Antagonists for Treating Cancer and Diagnostics Related Thereto

#11228
20220175763
2022-06-09

COMPOSITIONS AND METHODS FOR ENHANCING CANCER IMMUNE CHECKPOINT THERAPY

#11229
20220175758
2022-06-09

COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

#11230
20220175749
2022-06-09

LANABECESTAT FOR WEIGHT LOSS

#11231
20220175747
2022-06-09

Opioid receptor ligands and methods of using and making same

#11232
20220175746
2022-06-09

Indane-amines as PD-L1 antagonists

#11233
20220175744
2022-06-09

COMBINATIONS OF TRANSCRIPTION INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS FOR TREATMENT OF DISEASE

#11234
20220175743
2022-06-09

Topical roflumilast formulation having antifungal properties

#11235
20220175738
2022-06-09

Tip60 Inhibitors and Methods of Use for Cardiovascular Disease

#11236
20220175737
2022-06-09

Combination of nitazoxanide and elafibranor for the treatment of immune diseases or inflammation

#11237
20220175735
2022-06-09

METHODS OF TREATING PULMONARY DISEASES AND DISORDERS

#11238
20220175731
2022-06-09

JAK1 pathway inhibitors for the treatment of vitiligo

#11239
20220175720
2022-06-09

COMBINED PREPARATION COMPRISING AN ANTHOCYANIN COMPOSITION AND AN ANTIVIRAL AGENT

#11240
20220175716
2022-06-09

Treatment of circadian rhythm disorders

#11241
20220175713
2022-06-09

DEPSIDE TRIMERIC COMPOUNDS FOR SKELETAL MUSCLE MODULATION

#11242
20220175709
2022-06-09

PHARMACEUTICAL COMPOSITION COMPRISING EICOSAPENTAENOIC ACID AND NICOTINIC ACID AND METHODS OF USING SAME

#11243
20220175706
2022-06-09

Calcium lactate compositions and methods of use

#11244
20220175701
2022-06-09

TREATMENT OF MAJOR DEPRESSIVE DISORDER AND SUICIDAL IDEATIONS THROUGH STIMULATION OF HIPPOCAMPAL NEUROGENESIS UTILIZING PLANT-BASED APPROACHES

#11245
20220175693
2022-06-09

DIETARY SUPPLEMENT COMPRISING LUTEIN FOR TELOMERE PROTECTION, AND METHOD FOR PRODUCTION THEREOF

#11246
20220175690
2022-06-09

NOVEL DRUG DELIVERY COMPOSITION AND PROCESS FOR BLOOD-BRAIN BARRIER CROSSING

#11247
20220175689
2022-06-09

NOVEL DRUG DELIVERY COMPOSITION AND PROCESS FOR BLOOD-BRAIN BARRIER CROSSING

#11248
20220175688
2022-06-09

POLYMERIC NANOPARTICLES

#11249
20220175676
2022-06-09

MULTIFUNCTIONAL POLYMER-NANOPARTICLE COMPOSITE FOR FIRST AID AND WOUND CARE APPLICATIONS

#11250
20220175673
2022-06-09

SURGICAL DEVICE

#11251
20220175665
2022-06-09

Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity

#11252
20220175664
2022-06-09

Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity

#11253
20220175639
2022-06-09

COSMETIC COTAINING ULTRAVIOLET WAVELENGTH CONVERTING SUBSTANCE AND MEDICINAL AGENT

#11254
20220175637
2022-06-09

COMPOSITION COTAINING ULTRAVIOLET WAVELENGTH-CONVERTING SUBSTANCE AND HYDROPHOBIZED SILICA AND/OR HYDROPHOBIZED STARCH

#11255
20220175009
2022-06-09

Nutritional composition and infant formula for promoting de novo myelination

#11256
20220175008
2022-06-09

Nutritional composition and infant formula for promoting myelination of the brain

#11257
20220174983
2022-06-09

PROBIOTICS FOR REDUCING METHANE PRODUCTION

#11258
20220170114
2022-06-02

BIOMARKERS OF CHRONIC LYMPHOCYTIC LEUKEMIA AND USE THEREOF

#11259
20220170107
2022-06-02

PHOSPHATIDYLINOSITOL-3-KINASE PATHWAY BIOMARKERS

#11260
20220170012
2022-06-02

RNA ENGINEERED T CELLS FOR THE TREATMENT OF CANCER

#11261
20220169965
2022-06-02

A MICRO PHYSIOLOGICAL MODEL FOR NEURONAL AND MUSCULAR DISEASES AND DISORDERS

#11262
20220169742
2022-06-02

Antagonistic CD40 monoclonal antibodies and uses thereof

#11263
20220169735
2022-06-02

Methods of sensitizing cancer to immunotherapy

#11264
20220169734
2022-06-02

Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)

#11265
20220169725
2022-06-02

BIO-RESPONSIVE ANTIBODY COMPLEXES FOR ENHANCED IMMUNOTHERAPY

#11266
20220169714
2022-06-02

COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES INVOLVING CXCL1 FUNCTION

#11267
20220169705
2022-06-02

TOPICAL APPLICATION FOR AN ANTI-HSV ANTIBODY

#11268
20220169694
2022-06-02

CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY

#11269
20220169685
2022-06-02

Treatment of ischemia

#11270
20220169669
2022-06-02

HIGH-AFFINITY CU(I) LIGANDS AND METHODS OF USE THEREOF

#11271
20220169650
2022-06-02

Tricyclic compounds

#11272
20220169646
2022-06-02

HETEROCYCLIC COMPOUNDS AND USES THEREOF

#11273
20220169632
2022-06-02

METHODS AND MATERIALS FOR INCREASING OR MAINTAINING NICOTINAMIDE MONONUCLEOTIDE ADENYLYL TRANSFERASE-2 (NMNAT2) POLYPEPTIDE LEVELS

#11274
20220169631
2022-06-02

TAIRE FAMILY KINASE INHIBITORS AND USES THEREOF

#11275
20220169628
2022-06-02

THERAPEUTIC AGENTS AND METHODS OF TREATMENT

#11276
20220169616
2022-06-02

Quinoline derivatives, processes for their preparation and uses thereof for the treatment of cancer

#11277
20220169615
2022-06-02

AMORPHOUS AND CRYSTALLINE FORMS OF IDO INHIBITORS

#11278
20220168568
2022-06-02

PERIPHERAL NERVE STIMULATION DEVICE FOR AFFECTING PARASYMPATHETIC AND SYMPATHETIC ACTIVITY TO ACHIEVE THERAPEUTIC EFFECTS

#11279
20220168444
2022-06-02

INFLAMMASOME-TARGETED RNA INTERFERENCE APPROACH TO TREATING KIDNEY INJURY AND DISEASE

#11280
20220168438
2022-06-02

COMBINATION OF ANTIBODY-PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE AND PARP INHIBITOR

#11281
20220168432
2022-06-02

MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES

#11282
20220168426
2022-06-02

Bioorthogonal compositions

#11283
20220168422
2022-06-02

COMPOSITIONS AND METHODS FOR MONITORING, DIAGNOSIS, PROGNOSIS, DETECTION, AND TREATMENT OF CANCER

#11284
20220168416
2022-06-02

Afucosylated Anti-FGFR2IIIB Antibodies

#11285
20220168396
2022-06-02

MULTI-RECEPTOR AGONIST AND MEDICAL USE THEREOF

#11286
20220168392
2022-06-02

Methods of Enhancing Protection Against Organ and Vascular Injury, Hematopoietic Recovery and Survival in Response to Total Body Radiation/Chemical Exposure

#11287
20220168385
2022-06-02

USE OF CYCLOSPORINE ANALOGUES AS ANTITHROMBOTIC AGENTS

#11288
20220168384
2022-06-02

Anti-Bacterial Combination Therapy

#11289
20220168380
2022-06-02

Formulations for treating cramps and spasms

#11290
20220168375
2022-06-02

TEA COMPOSITION HAVING EFFICACY FOR PREVENTING OR IMPROVING RESPIRATORY DISEASES, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

#11291
20220168364
2022-06-02

Modified microorganisms expressing saga and related compositions for immunomodulation against infection and cancer immunotherapy

#11292
20220168353
2022-06-02

FREEZE-DRIED PLATELET DERIVATIVE COMPOSITIONS FOR TREATING ANTIPLATELET INDUCED COAGULOPATHY

#11293
20220168333
2022-06-02

Combination Treatment for Hematological Cancers

#11294
20220168331
2022-06-02

PRR-Activating and MicroRNA-Inhibiting Molecules and Methods of Using Same

#11295
20220168329
2022-06-02

COMBINATORIAL DRUG TREATMENT OF CANCER

#11296
20220168328
2022-06-02

METHODS AND COMPOSITIONS FOR TREATING EUKARYOTIC INFECTIONS VIA ALTERING AGGREGATION DYNAMICS OF RAPTOR/KOG1

#11297
20220168326
2022-06-02

THERAPEUTIC COMBINATIONS COMPRISING ANTI-FOLR1 IMMUNOCONJUGATES

#11298
20220168324
2022-06-02

CANCER THERAPY

#11299
20220168322
2022-06-02

NOVEL STAT3 INHIBITORS IDENTIFIED BY STRUCTURE-BASED VIRTUAL SCREENING INCORPORATING SH2 DOMAIN FLEXIBILITY

#11300
20220168319
2022-06-02

COMBINED USE OF A-NOR-5alpha ANDROSTANE COMPOUND DRUG AND ANTICANCER DRUG

#11301
20220168315
2022-06-02

COMPOUNDS AND THERAPEUTIC USES THEREOF

#11302
20220168313
2022-06-02

HETEROCYCLIC COMPOUNDS AND USES THEREOF

#11303
20220168296
2022-06-02

METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS

#11304
20220168294
2022-06-02

TREATMENT OF CNS CONDITIONS

#11305
20220168286
2022-06-02

TREATMENT OF RAYNAUD'S DISEASE

#11306
20220168283
2022-06-02

Treatment of progressive neurodegenerative disease with ibudilast

#11307
20220168279
2022-06-02

METHODS OF TREATING PAIN WITH A THIAZOLINE ANTI-HYPERALGESIC

#11308
20220168273
2022-06-02

Pharmaceutical combination for the treatment of cancer

#11309
20220168270
2022-06-02

COMPOSITIONS FOR PATHOGENESIS-DIRECTED THERAPY AND TREATMENTS OF SKIN DISEASES AND DISORDERS

#11310
20220168264
2022-06-02

Treatment of circadian rhythm disorders

#11311
20220168263
2022-06-02

Treatment of circadian rhythm disorders

#11312
20220168260
2022-06-02

Methods and compositions to treat and diagnose diseases or pathologies associated with inflammation of the sinuses and nasal cavity

#11313
20220168258
2022-06-02

METHOD FOR TREATING FEMALE NON-SMOKERS WITH NON-SMALL CELL LUNG CANCER

#11314
20220168254
2022-06-02

PARENTERAL NUTRITION FORMULATION WITH OPTIMIZED AMINO ACID AND GLUCOSE CONTENT

#11315
20220168249
2022-06-02

METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE

#11316
20220168247
2022-06-02

Topical compositions for pain relief, manufacture and use

#11317
20220168244
2022-06-02

Bis-Biguanide Compounds, Pharmaceutical Compositions and Uses in Managing Cancer

#11318
20220168243
2022-06-02

CORONAVIRUS TREATMENT COMPOSITIONS AND METHODS

#11319
20220168242
2022-06-02

PHARMACEUTICALLY ACCEPTABLE SALTS OF MESDOPETAM AND USES THEREOF

#11320
20220168240
2022-06-02

CANCER THERAPY BY INTRATUMORAL INJECTION OF A CHEMOTHERAPEUTIC AGENT IN COMBINATION WITH A BIOACTIVE IMMUNOSTIMULATORY AGENT

#11321
20220168229
2022-06-02

BIODEGRADABLE EXTENDED RELEASE MICROSPHERE-HYDROGEL OCULAR DRUG DELIVERY SYSTEM AND METHOD

#11322
20220168226
2022-06-02

SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH METFORMIN

#11323
20220167650
2022-06-02

HIGH-INTENSITY OUTDOOR SPORTS FOOD SUPPLEMENT RICH IN BIOLOGICAL IONS AND PREPARATION METHOD THEREOF

#11324
20220162616
2022-05-26

DUAL INHIBITION OF PLEXIN-B1 AND PLEXIN-B2

#11325
20220162597
2022-05-26

Compound for treatment of heart failure

#11326
20220162557
2022-05-26

Methods, compositions, and kits for producing beige adipocytes and treating metabolic disorders

#11327
20220162537
2022-05-26

FLUID SYSTEM FOR PRODUCING EXTRACELLULAR VESICLES COMPRISING A THERAPEUTIC OR IMAGING AGENT AND METHOD THEREOF

#11328
20220162338
2022-05-26

Anti-FXI/FXIa antibody and use thereof

#11329
20220162334
2022-05-26

METHODS AND COMPOSITIONS FOR ANTI-CD73 ANTIBODIES AND VARIANTS

#11330
20220162328
2022-05-26

INTERLEUKIN-4 RECEPTOR ANTIBODY AND APPLICATION THEREOF

#11331
20220162326
2022-05-26

Anti-IL36R antibodies

#11332
20220162323
2022-05-26

Anti-FGFR2 antibodies and methods of use thereof

#11333
20220162321
2022-05-26

ADMINISTRATION OF AGENTS FOR THE TREATMENT OF INFLAMMATION

#11334
20220162317
2022-05-26

Anti-CD112R compositions and methods

#11335
20220162310
2022-05-26

ANTIBODY TO TIGIT AND USE THEREOF

#11336
20220162308
2022-05-26

Anti-CD48 antibodies, antibody drug conjugates, and uses thereof

#11337
20220162301
2022-05-26

HUMANIZED ANTI-FOLATE RECEPTOR 1 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

#11338
20220162279
2022-05-26

COMBINATION IMMUNOTHERAPY

#11339
20220162278
2022-05-26

CARBAMOYL PHOSPHATE SYNTHATASE-1 FOR THE TREATMENT AND PREVENTION OF LIVER INJURY

#11340
20220162229
2022-05-26

HETEROCYCLIC COMPOUNDS AND USES THEREOF

#11341
20220162214
2022-05-26

Polymorphs of a kinase inhibitor, pharmaceutical compositions containing such a compound, preparation methods, and applications

#11342
20220162163
2022-05-26

ALANINE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE

#11343
20220162158
2022-05-26

Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors

#11344
20220162146
2022-05-26

4-hydroxybutyric acid analogs

#11345
20220161054
2022-05-26

SYSTEMS AND METHODS FOR PHOTOBIOMODULATION

#11346
20220160899
2022-05-26

COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA

#11347
20220160889
2022-05-26

ANTI-FOLR1 IMMUNOCONJUGATES AND ANTI-PD-1 ANTIBODY COMBINATIONS

#11348
20220160872
2022-05-26

Drug Adsorbed Highly Porous Activated Carbon for Enhanced Drug Delivery

#11349
20220160842
2022-05-26

METHOD OF TREATING INFECTIVE ENDOCARDITIS

#11350
20220160839
2022-05-26

METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS

#11351
20220160833
2022-05-26

METHODS FOR DETECTING AND MODULATING THE EMBRYONIC-FETAL TRANSITION IN MAMMALIAN SPECIES

#11352
20220160830
2022-05-26

COMPOSITIONS COMPRISING CHOLINE

#11353
20220160829
2022-05-26

USE OF ANNEXIN V AS A METHOD TO BLOCK TUMOR INDUCED IMMUNOSUPPRESSION OF THE INNATE IMMUNE RESPONSE

#11354
20220160824
2022-05-26

COMPOUNDS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE

#11355
20220160823
2022-05-26

Modulation of tumor immunity by protein-mediated Odelivery

#11356
20220160818
2022-05-26

Pharmaceutical compositions

#11357
20220160814
2022-05-26

COMPOSITIONS AND METHODS FOR PROTECTING TYPE 2 ALVEOLAR EPITHELIAL CELLS (AEC2)

#11358
20220160813
2022-05-26

Inhibitors for proliferating cell nuclear antigen and uses

#11359
20220160802
2022-05-26

METHODS AND COMPOSITIONS FOR PROMOTING HEALTH IN A SUBJECT

#11360
20220160799
2022-05-26

Methods for treating microbial infections using caudovirales bacteriophages

#11361
20220160794
2022-05-26

USE OF BACILLUS AMYLOLIQUEFACIENS AND/OR BACILLUS SUBTILIS FOR THE ENHANCEMENT OF ACTIVE PROBIOTIC COMPOSITIONS OR FOR THE ACTIVATION OF INACTIVE PROBIOTIC COMPOSITIONS, COMPOSITIONS THUS OBTAINED, AND RELATED METHOD

#11362
20220160793
2022-05-26

BACILLUS COAGULANS AND BACILLUS SUBTILIS FOR THE PREVENTION AND TREATMENT OF FUNCTIONAL GASTRO-INTESTINAL DISORDERS

#11363
20220160773
2022-05-26

Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the treatment of cancer

#11364
20220160772
2022-05-26

Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the treatment of cancer

#11365
20220160756
2022-05-26

Carbon monoxide-based therapies and implantable devices for the treatment of vascular disease

#11366
20220160754
2022-05-26

Derivatized chitosan polymers and methods of treating vascular disorders

#11367
20220160751
2022-05-26

METHODS OF TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH INCREASED TET LEVEL, INCREASED H19 LEVEL, INCREASED LEVEL OF TGF SIGNALING, OR ANY COMBINATION THEREOF

#11368
20220160749
2022-05-26

MIR-181 INHIBITORS AND USES THEREOF

#11369
20220160741
2022-05-26

Method and compositions for treating Coronavirus infection

#11370
20220160739
2022-05-26

METHODS FOR TREATING SUBJECTS WITH CHRONIC KIDNEY DISEASE

#11371
20220160736
2022-05-26

NITRIC OXIDE-RELEASING ANTIBACTERIAL COMPOUNDS, FORMULATIONS, AND METHODS PERTAINING THERETO

#11372
20220160734
2022-05-26

TREATMENT OF FIBROIDS WITH VITAMIN D AND AN AGENT SUCH AS EPIGALLOCATECHIN GALLATE (EGCG)

#11373
20220160727
2022-05-26

Method for the treatment of Dravet Syndrome

#11374
20220160721
2022-05-26

METHODS OF TREATING CANCER

#11375
20220160718
2022-05-26

COMPOSITIONS AND METHODS OF TREATING CANCER

#11376
20220160713
2022-05-26

SELECTIVE INHIBITOR OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5)

#11377
20220160710
2022-05-26

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE

#11378
20220160708
2022-05-26

Methods and Compositions for Reducing Side Effects in Chemotherapeutic Treatments

#11379
20220160706
2022-05-26

PHARMACEUTICAL COMBINATION COMPRISING TNO155 AND A PD-1 INHIBITOR

#11380
20220160703
2022-05-26

TUMOR-SELECTIVE COMBINATION THERAPY

#11381
20220160690
2022-05-26

Methods for Treatment of Fabry Disease

#11382
20220160686
2022-05-26

Macrocyclic azolopyridine derivatives as EED and PRC2 modulators

#11383
20220160679
2022-05-26

COMPOSITIONS AND METHODS FOR CANCER THERAPY

#11384
20220160671
2022-05-26

Antiviral therapeutic compounds and compositions for use in treatment of coronavirus and influenza virus

#11385
20220160669
2022-05-26

PARENTERAL NUTRITION FORMULATION

#11386
20220160662
2022-05-26

COMPOUNDS AND METHODS FOR TREATING ABERRANT ADRENOCORTICAL CELL DISORDERS

#11387
20220160660
2022-05-26

Deuterated forms of acetaminophen and uses thereof

#11388
20220160658
2022-05-26

TESOFENSINE FOR REDUCTION OF BODY WEIGHT IN PRADER-WILLI PATIENTS

#11389
20220160652
2022-05-26

USE OF VITAMIN K IN COMBINATION WITH ANTICOAGULANTS

#11390
20220160649
2022-05-26

PHARMACEUTICAL COMPOSITION

#11391
20220160644
2022-05-26

Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery

#11392
20220160641
2022-05-26

CAPSULE WITH INTERNAL DIAPHRAGM FOR IMPROVED BIOAVAILABILITY

#11393
20220160640
2022-05-26

ALCOHOL-RESISTANT DRUG FORMULATIONS

#11394
20220160620
2022-05-26

FORMULATIONS FOR TREATING PSORIASIS

#11395
20220160618
2022-05-26

Pharmaceutical formulation

#11396
20220154296
2022-05-19

USE OF ANTI-PD-1 ANTIBODY IN PREPARATION OF MEDICAMENT FOR TREATING SOLID TUMORS

#11397
20220154295
2022-05-19

METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER

#11398
20220154220
2022-05-19

SMALL MOLECULES FOR INCREASING PRECISE GENOME EDITING EFFICIENCY

#11399
20220153876
2022-05-19

BISPECIFIC ANTIBODIES FOR USE IN STEM CELL TRANSPLANTATION

#11400
20220153856
2022-05-19

Antagonistic CD40 monoclonal antibodies and uses thereof